Our main production base is located in Xuzhou industry park. We are certified both to the ISO 9001 and ISO 14001 Standards, have a safety management system in place.Our R&D team masters core technology for process-design of target building block

(trans,trans)-4-broMo-4'-pentyl-1,1'-Bicyclohexane Basic information Product Name: (trans,trans)-4-broMo-4'-pentyl-1,1'-Bicyclohexane Synonyms: (trans,trans)-4-broMo-4&#3

1)quick response within 12 hours; 2)quality guarantee: all products are strictly tested by our qc, confirmed by qa and approved by third party lab in china, usa, canada, germany, uk, italy, france etc. 3) oem/odm available; 4) rea

1.A strong technical force and advanced processing equipments. The quality of the products has been strictly inspected and all kinds of index have reached or exceeded domestic and international standards.2. Now we have established long-term stable re

Jinhua huayi chemical co., ltd. is dedicated to the development, production and marketing of chemicals. On the basis of equality and mutual benefit, and under the principle of customer first, credit first, quality first, we are ready to join hands

★.Best quality according to requirement ★.Competitive price in China market ★.Mature Technical support ★.Professional logistic support

factory?direct?saleAppearance:White powder Storage:Sealed and preserved Package:200/Kilograms Application:healing drugs Transportation:By sea Port:Shanghai/tianjin

CHEAP PRICE AND GOOD QUALITYAppearance:white powder Storage:At cool and dry place Package:5g;10g;100g;500g;1kg;25kg Application:PHARMACEUTICAL INTERMEDIATES Transportation:BY AIR

Supplement, prompt shipment, high purity Application:powder material

≥99%, stock Storage:Normal temperature to avoid light preservation Transportation:by air, by sea

High purity,Competitive Price,Leading Company in the filed. Application:Liquid crystal monomer

With certain technical reserves, high quality, preferential price and excellent service Application:Synthesis of pharmaceutical raw materials and research and development of new drugs